CADA, a Potential Anti-HIV Microbicide that Specifically Targets the Cellular CD4 Receptor
Journal:
Current HIV Research
Volume:
6
Page:
246-256
Author(s):
Kurt Vermeire, Joachim Brouwers, Yven Van Herrewege, Roger Le Grand, Guido Vanham, Patrick Augustijns, Thomas W. Bell and Dominique Schols
STAT 3 as a Target for Cancer Drug Discovery
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
834-843
Author(s):
Luca Costantino and Daniela Barlocco
Molecular Targets and Targeted Therapies for Malignant Mesothelioma
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
855-867
Author(s):
Camilla Palumbo, Roberto Bei, Antonio Procopio and Andrea Modesti
Viral Vectors in Cancer Immunotherapy: Which Vector for Which Strategy?
Journal:
Current Gene Therapy
Volume:
8
Page:
66-78
Author(s):
Sara A. Collins, Barbara-ann Guinn, Patrick T. Harrison, Martina F. Scallan, Gerald C. O'Sullivan and Mark Tangney
Human Hematopoietic Stem Cells in Gene Therapy: Pre-Clinical and Clinical Issues
Journal:
Current Gene Therapy
Volume:
8
Page:
135-146
Author(s):
Alessandra Biffi and Martina Cesani
ANTI-ADHESION Evolves To a Promising Therapeutic Concept in Oncology
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
978-990
Author(s):
R. Schmidmaier and P. Baumann
On the Epistemological Crisis in Genomics
Journal:
Current Genomics
Volume:
9
Page:
69-79
Author(s):
Edward R. Dougherty
MicroRNA and Cancer: Tiny Molecules with Major Implications
Journal:
Current Genomics
Volume:
9
Page:
97-109
Author(s):
Timothy G. VandenBoom II, Yiwei Li, Philip A. Philip and Fazlul H. Sarkar
Structure-Based Rationale for Interleukin 5 Receptor Antagonism
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1231-1239
Author(s):
Tetsuya Ishino, Adrian E. Harrington, Hosahudya Gopi and Irwin Chaiken
Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1058-1077
Author(s):
Snezana K. Bjelogrlic, Sinisa Radulovic and Nada Babovic